You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 185 Camrelizumab monotherapy or combination therapy in patients with recurrent or metastatic cervical and endometrial carcinoma:a retrospective study

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Checkpoint blockade therapy
185 Camrelizumab monotherapy or combination therapy in patients with recurrent or metastatic cervical and endometrial carcinoma:a retrospective study

 

Online download statistics by month:

Online download statistics by month: November 2020 to June 2025

AbstractFullPdf
Nov 2020106011
Dec 202018010
Jan 20213400
Feb 202152021
Mar 20214808
Apr 20211804
May 2021105
Jun 2021006
Jul 20210011
Aug 2021005
Sep 2021008
Oct 202116029
Nov 202128017
Dec 20212604
Jan 202212010
Feb 20221203
Mar 20221202
Apr 202248011
May 20224005
Jun 20221801
Jul 2022801
Aug 20222608
Sep 20221804
Oct 20222001
Nov 20223004
Dec 20221402
Jan 20231402
Feb 20231203
Mar 20231601
Apr 2023608
May 2023400
Jun 20231202
Jul 20231802
Aug 20231403
Sep 2023400
Oct 20231003
Nov 20231403
Dec 20235200
Jan 20241800
Feb 20243000
Mar 20242405
Apr 20242602
May 20241000
Jun 20243401
Jul 2024800
Aug 20241602
Sep 20243408
Oct 2024803
Nov 20241000
Dec 2024401
Jan 2025407
Feb 2025204
Mar 2025001
Apr 2025004
May 2025002
Jun 2025004
Total10090262